Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Warren Chow

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Cancer Chemotherapy and Pharmacology|June 9, 2004
Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancerRobert J Morgan, Timothy W Synold, David Gandara, et al.
Cancer Treatment and Research Communications|July 8, 2019
Randomized trial of oral cyclophosphamide versus oral cyclophosphamide with celecoxib for recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancerRohan Gupta, Mihaela Cristea, Paul Frankel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2007
Phase I trial of intraperitoneal gemcitabine in the treatment of advanced malignancies primarily confined to the peritoneal cavityRobert J Morgan, Timothy W Synold, Bixin Xi, et al.
The Oncologist|July 24, 2020
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment-Refractory Liposarcoma: Results from the SARC024 StudyRichard F Riedel, Karla V Ballman, Yao Lu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 20, 2007
Bone cancerJ Sybil Biermann, Douglas Adkins, Robert Benjamin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 13, 2009
Bone cancer clinical practice guidelinesJ Sybil Biermann, Laurence H Baker, Robert Benjamin, et al.
Investigational New Drugs|February 12, 2013
First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignanciesGlen J Weiss, Joseph Chao, Jeffrey D Neidhart, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 29, 2010
Bone cancerJ Sybil Biermann, Douglas R Adkins, Robert S Benjamin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 8, 2013
Bone cancerJ Sybil Biermann, Douglas R Adkins, Mark Agulnik, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 12, 2017
NCCN Guidelines Insights: Bone Cancer, Version 2.2017J Sybil Biermann, Warren Chow, Damon R Reed, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Cancer Chemotherapy and Pharmacology|June 9, 2004
Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancerRobert J Morgan, Timothy W Synold, David Gandara, et al.
Cancer Treatment and Research Communications|July 8, 2019
Randomized trial of oral cyclophosphamide versus oral cyclophosphamide with celecoxib for recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancerRohan Gupta, Mihaela Cristea, Paul Frankel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2007
Phase I trial of intraperitoneal gemcitabine in the treatment of advanced malignancies primarily confined to the peritoneal cavityRobert J Morgan, Timothy W Synold, Bixin Xi, et al.
The Oncologist|July 24, 2020
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment-Refractory Liposarcoma: Results from the SARC024 StudyRichard F Riedel, Karla V Ballman, Yao Lu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 20, 2007
Bone cancerJ Sybil Biermann, Douglas Adkins, Robert Benjamin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 13, 2009
Bone cancer clinical practice guidelinesJ Sybil Biermann, Laurence H Baker, Robert Benjamin, et al.
Investigational New Drugs|February 12, 2013
First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignanciesGlen J Weiss, Joseph Chao, Jeffrey D Neidhart, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 29, 2010
Bone cancerJ Sybil Biermann, Douglas R Adkins, Robert S Benjamin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 8, 2013
Bone cancerJ Sybil Biermann, Douglas R Adkins, Mark Agulnik, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 12, 2017
NCCN Guidelines Insights: Bone Cancer, Version 2.2017J Sybil Biermann, Warren Chow, Damon R Reed, et al.
Pageof 4